Literature DB >> 27160040

Evaluation of potentially achievable vaccination coverage with simultaneous administration of vaccines among children in the United States.

Zhen Zhao1, Philip J Smith2, Holly A Hill2.   

Abstract

BACKGROUND: Routine administration of all age-appropriate doses of vaccines during the same visit is recommended for children by the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
METHODS: Evaluate the potentially achievable vaccination coverage for ≥4 doses of diphtheria and tetanus toxoids and acellular pertussis vaccine (4+DTaP), ≥4 doses of pneumococcal conjugate vaccine (4+PCV), and the full series of Haemophilus influenzae type b vaccine (Hib-FS) with simultaneous administration of all recommended childhood vaccines. Compare the potentially achievable vaccination coverage to the reported vaccination coverage for calendar years 2001 through 2013; by state in the United States and by selected socio-demographic factors in 2013. The potentially achievable vaccination coverage was defined as the coverage possible for the recommended 4+DTaP, 4+PCV, and Hib-FS if missed opportunities for simultaneous administration of all age-appropriate doses of vaccines for children had been eliminated.
RESULTS: Compared to the reported vaccination coverage, the potentially achievable vaccination coverage for 4+DTaP, 4+PCV, and Hib-FS could have increased significantly (P<0.001), the vaccination coverage would have achieved the 90% target of Healthy People 2020 for the three vaccines beginning in 2005, 2008, and 2011 respectively. In 2013, the potentially achievable vaccination coverage increased significantly across all selected socio-demographic factors, potentially achievable vaccination coverage would have reached the 90% target for more than 51% of the states in the United States.
CONCLUSIONS: The findings in this study suggest that fully utilization of all opportunities for simultaneous administration of all age-eligible childhood doses of vaccines during the same vaccination visit is a critical strategy for achieving the vaccination coverage target of Healthy People 2020. Encouraging providers to deliver all recommended vaccines that are due at each visit by implementing client reminder and recall systems might decrease missed opportunities for simultaneous administration of childhood vaccines. Published by Elsevier Ltd.

Entities:  

Keywords:  Age appropriate; Childhood vaccines; Healthy People 2020 target; Potentially achievable; Simultaneous administration; Vaccination coverage

Mesh:

Substances:

Year:  2016        PMID: 27160040      PMCID: PMC6714559          DOI: 10.1016/j.vaccine.2016.04.097

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Missed opportunities for simultaneous administration of the fourth dose of DTaP among children in the United States.

Authors:  Zhen Zhao; Philip J Smith; Holly A Hill
Journal:  Vaccine       Date:  2017-05-04       Impact factor: 3.641

2.  Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines.

Authors:  Shirley V Wang; Abdurrahman Abdurrob; Julia Spoendlin; Edwin Lewis; Sophia R Newcomer; Bruce Fireman; Matthew F Daley; Jason M Glanz; Jonathan Duffy; Eric S Weintraub; Martin Kulldorff
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-13       Impact factor: 2.890

3.  Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event.

Authors:  Shirley V Wang; Kristina Stefanini; Edwin Lewis; Sophia R Newcomer; Bruce Fireman; Matthew F Daley; Jason M Glanz; Jonathan Duffy; Eric Weintraub; Martin Kulldorff
Journal:  Drug Saf       Date:  2020-10       Impact factor: 5.606

4.  Improving childhood vaccination coverage rates: the case of fourth dose of DTaP.

Authors:  Sarah J Clark; Anne E Cowan; Katelyn Wells
Journal:  Hum Vaccin Immunother       Date:  2020-02-04       Impact factor: 3.452

5.  Vaccination Coverage Among Children Aged 19-35 Months - United States, 2017.

Authors:  Holly A Hill; Laurie D Elam-Evans; David Yankey; James A Singleton; Yoonjae Kang
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-10-12       Impact factor: 17.586

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.